
Blog|Articles|February 9, 2022
Interactive Case Study in Migraine Prevention
Advertisement
We invite you to navigate through the treatment journey of a patient living with migraine.
Explore the individual patient outcomes and learn about the efficacy and safety of a monoclonal antibody for the preventive treatment of migraine.
This program is intended for US audiences only. This program is not approved for continuing medical education (CME) credit. ©2022. Lundbeck. All rights reserved. MIG-D-100153.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Preliminary Phase 2 Data Support Therapeutic Development of Synaptic Regenerative Drug SPG302 in ALS
2
Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows
3
Therapeutic Promise and Mechanism of DYNE-101 to Treat Myotonic Dystrophy: Doug Kerr, MD, PhD
4
Ensuring a Comprehensive Diagnosis of CIDP and the Role of EMG
5




































